Literature DB >> 18954864

The elucidation of the structure of the core part of the LPS from Plesiomonas shigelloides serotype O17 expressing O-polysaccharide chain identical to the Shigella sonnei O-chain.

Joanna Kubler-Kielb1, Rachel Schneerson, Chris Mocca, Evgeny Vinogradov.   

Abstract

Plesiomonas shigelloides O17 LPS contains the same O-antigenic polysaccharide chain as a causative agent of dysentery, Shigella sonnei. This polysaccharide can be used as a component of a vaccine against dysentery. Core part of the P. shigelloides O17 LPS was studied using NMR and mass spectrometry and the following structure was proposed: [structure : see text]. Significant similarity of the P. shigelloides O17 LPS core with the structure of the P. shigelloides O54 core was observed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18954864      PMCID： PMC2593084          DOI： 10.1016/j.carres.2008.09.017

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN： 0008-6215            Impact factor:   2.104


  10 in total

1.  Comparison of O-antigen gene clusters of Escherichia coli (Shigella) sonnei and Plesiomonas shigelloides O17: sonnei gained its current plasmid-borne O-antigen genes from P. shigelloides in a recent event.

Authors:  J G Shepherd; L Wang; P R Reeves
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 2.  Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins.

Authors:  O Westphal; K Jann; K Himmelspach
Journal:  Prog Allergy       Date:  1983

3.  Core oligosaccharides of Plesiomonas shigelloides O54:H2 (strain CNCTC 113/92): structural and serological analysis of the lipopolysaccharide core region, the O-antigen biological repeating unit, and the linkage between them.

Authors:  Tomasz Niedziela; Jolanta Lukasiewicz; Wojciech Jachymek; Monika Dzieciatkowska; Czeslaw Lugowski; Lennart Kenne
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

4.  Identification of Shigella sonnei form I plasmid genes necessary for cell invasion and their conservation among Shigella species and enteroinvasive Escherichia coli.

Authors:  H Watanabe; A Nakamura
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

5.  The structure of the rough-type lipopolysaccharide from Shewanella oneidensis MR-1, containing 8-amino-8-deoxy-Kdo and an open-chain form of 2-acetamido-2-deoxy-D-galactose.

Authors:  Evgeny Vinogradov; Anton Korenevsky; Terry J Beveridge
Journal:  Carbohydr Res       Date:  2003-09-10       Impact factor: 2.104

6.  Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.

Authors:  D Cohen; S Ashkenazi; M S Green; M Gdalevich; G Robin; R Slepon; M Yavzori; N Orr; C Block; I Ashkenazi; J Shemer; D N Taylor; T L Hale; J C Sadoff; D Pavliakova; R Schneerson; J B Robbins
Journal:  Lancet       Date:  1997-01-18       Impact factor: 79.321

7.  Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.

Authors:  D N Taylor; A C Trofa; J Sadoff; C Chu; D Bryla; J Shiloach; D Cohen; S Ashkenazi; Y Lerman; W Egan
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Structure of the lipid A-inner core region and biological activity of Plesiomonas shigelloides O54 (strain CNCTC 113/92) lipopolysaccharide.

Authors:  Jolanta Lukasiewicz; Tomasz Niedziela; Wojciech Jachymek; Lennart Kenne; Czeslaw Lugowski
Journal:  Glycobiology       Date:  2006-02-20       Impact factor: 4.313

9.  Protection from Shigella sonnei infection by immunisation of rabbits with Plesiomonas shigelloides (SVC 01).

Authors:  S Sayeed; D A Sack; F Qadri
Journal:  J Med Microbiol       Date:  1992-12       Impact factor: 2.472

Review 10.  Plesiomonas shigelloides septicemia: case report and literature review.

Authors:  A C Lee; K Y Yuen; S Y Ha; D C Chiu; Y L Lau
Journal:  Pediatr Hematol Oncol       Date:  1996 May-Jun       Impact factor: 1.969
  10 in total
  12 in total

Review 1.  Plesiomonas shigelloides Revisited.

Authors:  J Michael Janda; Sharon L Abbott; Christopher J McIver
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates.

Authors:  John B Robbins; Joanna Kubler-Kielb; Evguenii Vinogradov; Christopher Mocca; Vince Pozsgay; Joseph Shiloach; Rachel Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-03       Impact factor: 11.205

3.  Genomic and proteomic studies on Plesiomonas shigelloides lipopolysaccharide core biosynthesis.

Authors:  Eleonora Aquilini; Susana Merino; Miguel Regué; Juan M Tomás
Journal:  J Bacteriol       Date:  2013-11-15       Impact factor: 3.490

Review 4.  The structural diversity of carbohydrate antigens of selected gram-negative marine bacteria.

Authors:  Evgeny L Nazarenko; Russell J Crawford; Elena P Ivanova
Journal:  Mar Drugs       Date:  2011-10-14       Impact factor: 6.085

Review 5.  The Rising Dominance of Shigella sonnei: An Intercontinental Shift in the Etiology of Bacillary Dysentery.

Authors:  Corinne N Thompson; Pham Thanh Duy; Stephen Baker
Journal:  PLoS Negl Trop Dis       Date:  2015-06-11

6.  Structural Masquerade of Plesiomonas shigelloides Strain CNCTC 78/89 O-Antigen-High-Resolution Magic Angle Spinning NMR Reveals the Modified d-galactan I of Klebsiella pneumoniae.

Authors:  Karolina Ucieklak; Sabina Koj; Damian Pawelczyk; Tomasz Niedziela
Journal:  Int J Mol Sci       Date:  2017-11-29       Impact factor: 5.923

7.  Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.

Authors:  Odile Launay; David J M Lewis; Alessandra Anemona; Pierre Loulergue; Jo Leahy; Antonella Silvia Sciré; Anaïs Maugard; Elisa Marchetti; Stefano Zancan; Zhiming Huo; Simona Rondini; Rachid Marhaba; Oretta Finco; Laura B Martin; Jochen Auerbach; Daniel Cohen; Allan Saul; Christiane Gerke; Audino Podda
Journal:  EBioMedicine       Date:  2017-07-15       Impact factor: 8.143

8.  NMR study of the O-specific polysaccharide and the core oligosaccharide from the lipopolysaccharide produced by Plesiomonas shigelloides O24:H8 (strain CNCTC 92/89).

Authors:  Lena C E Lundqvist; Marta Kaszowska; Corine Sandström
Journal:  Molecules       Date:  2015-04-01       Impact factor: 4.411

9.  Core oligosaccharide of Plesiomonas shigelloides PCM 2231 (Serotype O17) lipopolysaccharide--structural and serological analysis.

Authors:  Anna Maciejewska; Jolanta Lukasiewicz; Marta Kaszowska; Aleksandra Man-Kupisinska; Wojciech Jachymek; Czeslaw Lugowski
Journal:  Mar Drugs       Date:  2013-02-06       Impact factor: 5.118

10.  Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults.

Authors:  Punnee Pitisuttithum; Dilara Islam; Supat Chamnanchanunt; Nattaya Ruamsap; Patchariya Khantapura; Jaranit Kaewkungwal; Chatporn Kittitrakul; Viravarn Luvira; Jittima Dhitavat; Malabi M Venkatesan; Carl J Mason; Ladaporn Bodhidatta
Journal:  Clin Vaccine Immunol       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.